Kǎlěi'ěr Dàinóng Yōushù Jījīn Xiēlì A Qiánxiān Pǐjiào Měigǔ Zhāogōusù (2025-05-21 Bǎn)

SUPPLEMENT NO. 2, DATED MAY21, 2025, TOPROSPECTUS SUPPLEMENT, DATED OCTOBER4, 2023 CARLYLE CREDIT INCOME FUNDUp to $125,000,000 of Common Shares This supplement is being filed to update, amend and supplement certain information in our prospectus dated September29, 2023, as supplementedby that prospectus supplement dated October4, 2023 and that supplement no. 1 dated November21, 2024 and as further supplemented as of the datehereof, pursuant to which we may offer and sell shares of our common shares of beneficial interest at an aggregate offering price of up to $125.0millionfrom time to time through the Placement Agents. Sales of our common shares, if any, under the prospectus supplement, as further supplemented as of thedate hereof, and the accompanying prospectus may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined This supplement should be read in conjunction with the prospectus supplement and accompanying prospectus. This supplement is only intended toupdate, amend and supplement certain information in the prospectus supplement to the extent set forth herein. Capitalized terms used and not defined This supplement is being filed to reflect that we, Carlyle Global Credit Investment Management L.L.C., B. Riley Securities, Inc., LadenburgThalmann& Co. Inc., Oppenheimer& Co. Inc. and Lucid Capital Markets, LLC have entered into Amendment No.3 to that certain Equity DistributionAgreement, dated October4, 2023 (as amended, restated, supplemented or otherwise modified from time to time, the “Equity Distribution Agreement”),in order to increase the aggregate offering price of sales of our common shares from $75.0million to $125.0million. Accordingly, each reference to The supplement is also being filed to further supplement the prospectus supplement to reflect that our investment adviser, Carlyle Global CreditInvestment Management L.L.C., may from time to time, in its sole discretion, pay some or all of the Placement Agents’ commission in order to ensurethat the sales price per share of our common shares in connection with all of the offerings made hereunder will not be less than our then-current net asset An investment in our common shares involves certain risks, including, among other things, the risk of leverage and risks relating toinvestments in equity and junior debt tranches of collateralized loan obligations. Common shares ofclosed-endmanagement investmentcompanies that are listed on an exchange frequently trade at a discount to their net asset value. If our common shares trade at a discount to ourNAV, it will likely increase the risk of loss for purchasers of our securities. You should review carefully the risks and uncertainties, including therisk of leverage, described in the section titled “Risk Factors” beginning on page 24 of the prospectus or otherwise included in or incorporated